WAINUA
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0310-9400 -
Package NDC
0310-9400-01 -
Application number
NDA217388 -
SPL ID
cea076d0-c827-4c46-9b36-418bf63d5a9d -
SPL set ID
d7dcb847-71dd-4fff-82d0-d43a465fc096 -
UNII
0GRZ0F5XJ6 -
RxCUI
2671944 -
RxCUI
2671950 -
RxCUI
2741485 -
RxCUI
2741488
What the source publishes
- Labeler
- AstraZeneca Pharmaceuticals LP
- Active ingredients
- EPLONTERSEN
- Form
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "WAINUA",
"splId": "cea076d0-c827-4c46-9b36-418bf63d5a9d",
"labels": [
{
"setId": "d7dcb847-71dd-4fff-82d0-d43a465fc096",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d7dcb847-71dd-4fff-82d0-d43a465fc096",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d7dcb847-71dd-4fff-82d0-d43a465fc096"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "AstraZeneca Pharmaceuticals LP",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 SYRINGE, GLASS in 1 CARTON (0310-9400-01) / .8 mL in 1 SYRINGE, GLASS",
"package_ndc": "0310-9400-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20231221"
}
],
"productId": "0310-9400_cea076d0-c827-4c46-9b36-418bf63d5a9d",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "0310-9400",
"deaSchedule": null,
"genericName": "EPLONTERSEN",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "EPLONTERSEN",
"strength": "45 mg/.8mL"
}
],
"applicationNumber": "NDA217388",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20231221",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000193849",
"N0000191626",
"M0025055",
"N0000008852",
"N0000009531"
],
"unii": [
"0GRZ0F5XJ6"
],
"rxcui": [
"2671944",
"2671950",
"2741485",
"2741488"
],
"spl_set_id": [
"d7dcb847-71dd-4fff-82d0-d43a465fc096"
],
"pharm_class_cs": [
"Oligonucleotides, Antisense [CS]"
],
"pharm_class_pe": [
"Decreased RNA Integrity [PE]",
"Increased Protein Breakdown [PE]"
],
"pharm_class_epc": [
"Transthyretin-directed RNA Interaction [EPC]",
"Antisense Oligonucleotide [EPC]"
],
"manufacturer_name": [
"AstraZeneca Pharmaceuticals LP"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0310-9400_cea076d0-c827-4c46-9b36-418bf63d5a9d"